The emerging treatment of this peptide represents a exciting development in the care of the condition. Distinct from existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) – leading to improved glucose reg